Related Experiment Video

Updated: Jun 23, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses

M Shiina1, M D Lacher, C Christian

  • 1Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143-0128, USA.

Cancer Gene Therapy
|May 2, 2009
PubMed

Insights

Loss of p21(WAF1) significantly enhances oncolytic adenovirus replication and cancer cell killing. Suppressing p21(WAF1) improves virus production and therapeutic efficacy, offering new strategies for adenoviral cancer therapy.

Area of Science:

  • Oncolytic virotherapy
  • Cancer biology
  • Molecular oncology

Background:

  • Oncolytic adenoviruses show therapeutic promise but require improved selectivity and efficacy.
  • Adenovirus replication and cancer cell lysis are key mechanisms for oncolytic virotherapy.
  • The role of specific cellular factors in regulating adenovirus replication needs further elucidation.

Purpose of the Study:

  • To investigate the impact of p21(WAF1) on the replication and cytolytic activity of oncolytic adenoviruses.
  • To determine if modulating p21(WAF1) levels can enhance the efficacy of adenoviral cancer therapy.
  • To explore the potential of p21(WAF1) as a predictive biomarker or therapeutic target in oncolytic virotherapy.

Main Methods:

  • Utilized HCT116 colon cancer cell lines with p21(WAF1) or p53 deletions.
  • Infected cell lines with wild-type adenovirus (WtD), ONYX-015, and Delta-24 oncolytic adenoviruses.
  • Employed siRNA-mediated knockdown of p21(WAF1) and p27(KIP1) in various cancer cell lines (HCT116, TE7, H1299, DU-145).
  • Assessed viral replication, virus production, and cytopathic effects.

Main Results:

  • HCT116 p21-/- cells exhibited significantly stronger cytopathic effects and increased virus production upon infection with WtD, ONYX-015, and Delta-24 compared to wild-type HCT116 cells.
  • siRNA-mediated knockdown of p21(WAF1) and p27(KIP1) in HCT116-WT cells enhanced adenovirus replication and cell killing.
  • Suppression of p21(WAF1) in TE7, H1299, and DU-145 cells also led to increased virus production following infection with ONYX-015 and Delta-24.
  • These findings were consistent across multiple cancer cell types and adenovirus constructs.

Conclusions:

  • Loss or suppression of p21(WAF1) promotes oncolytic adenovirus replication and enhances cancer cell killing.
  • p21(WAF1) plays a crucial role in mediating the replication of oncolytic adenoviruses.
  • Modulating p21(WAF1) expression presents a promising strategy to improve the efficacy of adenoviral-based cancer therapies.

More Related Videos

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...